4AE4
The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a novel SOUBA domain
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A (A) | UBIQUITIN-ASSOCIATED PROTEIN 1 | polymer | 118 | 13800.4 | 1 | UniProt (Q9NZ09) Pfam (PF22567) Pfam (PF21267) | HOMO SAPIENS (HUMAN) | UBAP-1, UBAP1, NASOPHARYNGEAL CARCINOMA-ASSOCIATED GENE 20 PROTEIN |
| 2 | B (B) | UBIQUITIN-ASSOCIATED PROTEIN 1 | polymer | 118 | 13832.4 | 1 | UniProt (Q9NZ09) Pfam (PF22567) Pfam (PF21267) | HOMO SAPIENS (HUMAN) | UBAP-1, UBAP1, NASOPHARYNGEAL CARCINOMA-ASSOCIATED GENE 20 PROTEIN |
| 3 | C, G (A, B) | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID | non-polymer | 207.3 | 2 | Chemie (NHE) | |||
| 4 | D, F, H, I (A, B) | POTASSIUM ION | non-polymer | 39.1 | 4 | Chemie (K) | |||
| 5 | E (A) | GLYCEROL | non-polymer | 92.1 | 1 | Chemie (GOL) | |||
| 6 | J (B) | SODIUM ION | non-polymer | 23.0 | 1 | Chemie (NA) | |||
| 7 | K, L (A, B) | water | water | 18.0 | 242 | Chemie (HOH) |
Sequence modifications
A: 389 - 502 (UniProt: Q9NZ09)
B: 389 - 502 (UniProt: Q9NZ09)
| PDB | External Database | Details |
|---|---|---|
| Gly 385 | - | expression tag |
| Ser 386 | - | expression tag |
| His 387 | - | expression tag |
| Mse 388 | - | expression tag |
| Ala 415 | Lys 415 | engineered mutation |
| Ala 416 | Lys 416 | engineered mutation |
| Ala 418 | Glu 418 | engineered mutation |
| PDB | External Database | Details |
|---|---|---|
| Gly 385 | - | expression tag |
| Ser 386 | - | expression tag |
| His 387 | - | expression tag |
| Mse 388 | - | expression tag |
| Ala 415 | Lys 415 | engineered mutation |
| Ala 416 | Lys 416 | engineered mutation |
| Ala 418 | Glu 418 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 27632.8 | |
| Non-Polymers* | Number of molecules | 8 |
| Total formula weight | 686.1 | |
| All* | Total formula weight | 28318.8 |






